Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling

Retrieved on: 2022-11-10 08:11:13

Tags for this article:

Branches of biology

Life Sciences

Emerging technologies

Genome editing

Biological engineering

Transcription activator-like effector nuclease

Forward-looking statement

Click the tags to see associated articles and topics

Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling. View article details on HISWAI: https://www.wdrb.com/news/national/cellectis-publishes-manuscript-in-frontiers-bioengineering-and-biotechnology-unveiling/article_7d616469-3fef-59b4-b67a-f7b2ff8811fa.html

Excerpt

NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology ...

Article found on: www.wdrb.com

View Original Article